Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
1651
Garmin
GRMN
$55.6B
| $5.19M | 0.01% |
96,182
+64,757
| +206% | +$3.35M |
|
|
DISCK
1652
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $5.17M | 0.01% |
255,417
+116,478
| +84% | +$2.62M |
|
|
MNK
1653
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.16M | 0.01% |
138,157
-642,433
| -82% | -$25.5M |
|
|
ACBI
1654
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $5.16M | 0.01% |
284,394
+264,107
| +1,302% | +$4.81M |
|
|
ICPT
1655
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.16M | 0.01% |
88,819
-100,764
| -53% | -$10.9M |
|
1656
Pitney Bowes
PBI
$2.34B
| $5.12M | 0.01% |
365,075
-144,447
| -28% | -$1.98M |
|
|
P
1657
DELISTED
Pandora Media Inc
P
| $5.11M | 0.01% |
662,971
-2,049,532
| -76% | -$17.6M |
|
|
CAJ
1658
DELISTED
Canon, Inc.
CAJ
| $5.1M | 0.01% |
+148,666
| New | +$5.12M |
|
1659
New Mountain Finance
NMFC
$719M
| $5.1M | 0.01% |
357,731
+76,940
| +27% | +$1.09M |
|
|
MRNS
1660
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.09M | 0.01% |
+216,982
| New | +$2.43M |
|
|
ALOG
1661
DELISTED
Analogic Corp
ALOG
| $5.09M | 0.01% |
60,785
-25,442
| -30% | -$1.85M |
|
1662
Jabil
JBL
$32.3B
| $5.09M | 0.01% |
178,230
-300,670
| -63% | -$9.09M |
|
1663
Syndax Pharmaceuticals
SNDX
$1.78B
| $5.08M | 0.01% |
434,244
-326,959
| -43% | -$4.01M |
|
|
WCC
1664
WESCO International
WCC
$16.5B
| $5.07M | 0.01% |
87,023
-249,644
| -74% | -$13.4M |
|
1665
ABM Industries
ABM
$2.73B
| $5.07M | 0.01% |
121,435
-224,742
| -65% | -$9.57M |
|
1666
Pacific Biosciences
PACB
$472M
| $5.05M | 0.01% |
962,221
+485,375
| +102% | +$2.09M |
|
|
CBB
1667
DELISTED
Cincinnati Bell Inc.
CBB
| $5.05M | 0.01% |
+254,266
| New | +$5.01M |
|
1668
Sabesp
SBS
$16.9B
| $5.05M | 0.01% |
2,487,341
-1,230,367
| -33% | -$2.49M |
|
1669
PUT
Vale
VALE
$65.2B
| $5.04M | 0.01% |
+500,000
| New | +$5.03M |
|
|
GNBC
1670
DELISTED
Green Bancorp, Inc
GNBC
| $5.03M | 0.01% |
212,716
+116,975
| +122% | +$2.49M |
|
1671
Wingstop
WING
$3.1B
| $5.03M | 0.01% |
151,127
-79,214
| -34% | -$2.57M |
|
1672
Atlassian
TEAM
$42.1B
| $5.02M | 0.01% |
+142,787
| New | +$5.07M |
|
1673
Upland Software
UPLD
$13.9M
| $5.01M | 0.01% |
+23,668
| New | +$5.43M |
|
|
MDP
1674
DELISTED
Meredith Corporation
MDP
| $5M | 0.01% |
90,116
-212,560
| -70% | -$12M |
|
1675
Novavax
NVAX
$1.56B
| $5M | 0.01% |
219,210
+199,330
| +1,003% | +$4.46M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.